James Schoeneck, John Kozarich, Robin Stracey, Tom Metcalfe, Geoffrey Duyk, Joseph Catino, William Hancock, Brian Huber, Colin McKerlie, Jill Mesirov, Peter Loescher, Andrew Carr, Peter Ehrenheim | GenomeWeb

James Schoeneck has become CEO of Activx Biosciences (see story, p. 3), and former CEO and chief scientific officer John Kozarich has become president and chief R&D officer of the company. Schoeneck was previously president and CEO of Prometheus Laboratories. Prior to joining Prometheus, he was vice president and general manager of the immunology business unit of Centocor, a division of Johnson & Johnson.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.